[Federal Register: September 2, 2003 (Volume 68, Number 169)]
[Notices]
[Page 52226]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr02se03-112]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances Notice of Registration
By Notice dated April 29, 2003, and published in the Federal
Register on May 29, 2003, (68 FR 32089), Organichem Corporation, 33
Riverside Avenue, Rensselaer, New York 12144, made application by
renewal to the Drug Enforcement Administration to be registered as a
bulk manufacturer of the basic class of Schedule II of controlled
substance listed below:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Dextropoxyphene (9273)..................... II
------------------------------------------------------------------------
The firm plans to manufacture bulk products for distribution to its
customers.
No comments or objections have been received. DEA has considered
the factors in Title 21, United States Code, Section 823(a) and
determined that the registration of Organichem Corporation to
manufacture the listed controlled substances is consistent with the
public interest at this time. DEA has investigated Organichem
Corporation to ensure that the company's registration is consistent
with the public interest. This investigation has included inspection
and testing of the company's physical security systems, verification of
the company's compliance with state and local laws, and a review of the
company's background and history. Therefore, pursuant to 21 U.S.C. 823
and 28 CFR 0.100 and 0.104, the Deputy Assistant Administrator, Office
of Diversion Control, hereby orders that the application submitted by
the above firm for registration as a bulk manufacturer of the basic
class of controlled substance listed is granted.
Dated: August 19, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 03-22325 Filed 8-29-03; 8:45 am]
BILLING CODE 4410-09-M